<DOC>
	<DOCNO>NCT00445770</DOCNO>
	<brief_summary>The purpose study examine effect etanercept ( 10 mg 25 mg ) compare methotrexate ( 8 mg per week ) slow joint destruction .</brief_summary>
	<brief_title>Study Evaluating Efficacy Safety Etanercept Methotrexate Japanese Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Must Japanese live Japan Must age 20 75 year Diagnosed less equal 10 year time first visit Anyone receive etanercept TNFinhibitors infliximab adalimumab past Patient rheumatic disease condition could predispose patient infection Pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Arthritis</keyword>
</DOC>